This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Leland Stanford Junior University, Massachusetts Institute of Technology. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Cary Francis Opel: Innovator in Cancer Treatment
Introduction
Cary Francis Opel is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on developing effective therapies for cancer patients, showcasing his dedication to improving healthcare outcomes.
Latest Patents
Cary Opel holds a patent for "Methods of treating cancer cells expressing tumor-associated integrins." This invention provides a method of treating cancer using a combination of IL-2 (e.g., extended-PK IL-2), an integrin-binding-Fc fusion protein, and a cancer vaccine. The methods outlined in his patent can be utilized to treat a broad range of cancer types, highlighting the potential impact of his work on cancer therapy.
Career Highlights
Throughout his career, Cary has worked with prestigious institutions such as Leland Stanford Junior University and the Massachusetts Institute of Technology. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Cary has collaborated with notable colleagues, including Karl Dane Wittrup and Darrell J Irvine. These partnerships have further enriched his research and have played a crucial role in advancing his innovative approaches to cancer treatment.
Conclusion
Cary Francis Opel's contributions to cancer treatment through his patented methods demonstrate his commitment to innovation in healthcare. His work not only reflects his expertise but also holds promise for improving the lives of cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile